Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$98.98 - $115.74 $71,067 - $83,101
718 Added 9.03%
8,669 $1 Million
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $6,551 - $7,641
-68 Reduced 0.85%
7,951 $817,000
Q1 2023

May 05, 2023

SELL
$107.32 - $113.5 $1.14 Million - $1.2 Million
-10,598 Reduced 56.93%
8,019 $875,000
Q4 2022

Feb 13, 2023

SELL
$62.39 - $113.8 $5,490 - $10,014
-88 Reduced 0.47%
18,617 $2.12 Million
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $2,769 - $3,979
-47 Reduced 0.25%
18,705 $1.16 Million
Q2 2022

Aug 12, 2022

BUY
$79.4 - $116.36 $714 - $1,047
9 Added 0.05%
18,752 $1.5 Million
Q1 2022

May 12, 2022

BUY
$86.42 - $109.81 $8,469 - $10,761
98 Added 0.53%
18,743 $1.97 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $40,311 - $49,043
-409 Reduced 2.15%
18,645 $2.01 Million
Q3 2021

Nov 10, 2021

SELL
$91.91 - $110.37 $18,198 - $21,853
-198 Reduced 1.03%
19,054 $2.09 Million
Q2 2021

Aug 11, 2021

SELL
$86.24 - $95.92 $43,033 - $47,864
-499 Reduced 2.53%
19,252 $1.8 Million
Q1 2021

May 10, 2021

BUY
$71.83 - $95.48 $414,746 - $551,301
5,774 Added 41.31%
19,751 $1.82 Million
Q4 2020

Feb 05, 2021

BUY
$67.0 - $84.39 $6,834 - $8,607
102 Added 0.74%
13,977 $1.02 Million
Q3 2020

Nov 03, 2020

SELL
$55.23 - $79.93 $64,563 - $93,438
-1,169 Reduced 7.77%
13,875 $1.08 Million
Q2 2020

Jul 28, 2020

SELL
$30.2 - $56.98 $33,944 - $64,045
-1,124 Reduced 6.95%
15,044 $837,000
Q1 2020

May 13, 2020

BUY
$24.87 - $38.56 $33,425 - $51,824
1,344 Added 9.07%
16,168 $479,000
Q4 2019

Feb 12, 2020

SELL
$25.43 - $36.67 $8,188 - $11,807
-322 Reduced 2.13%
14,824 $536,000
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $23,989 - $29,172
-1,043 Reduced 6.44%
15,146 $412,000
Q2 2019

Aug 12, 2019

BUY
$22.81 - $28.48 $369,271 - $461,062
16,189 New
16,189 $390,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.